COVID-19 Vaccination: From Interesting Agent to the Patient
<p dir="ltr">The vaccination for the novel Coronavirus (COVID-19) is undergoing its final stages of analysis and testing. It is an impressive feat under the circumstances that we are on the verge of a potential breakthrough vaccination. This will help reduce the stress for millions o...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513564221374464 |
|---|---|
| author | Anis Daou (16442181) |
| author_facet | Anis Daou (16442181) |
| author_role | author |
| dc.creator.none.fl_str_mv | Anis Daou (16442181) |
| dc.date.none.fl_str_mv | 2021-01-03T00:00:00Z |
| dc.identifier.none.fl_str_mv | 10.3390/vaccines9020120 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/COVID-19_Vaccination_From_Interesting_Agent_to_the_Patient/23576073 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Clinical sciences Immunology Pharmacology and pharmaceutical sciences COVID-19 vaccination severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drug development and discovery pandemic |
| dc.title.none.fl_str_mv | COVID-19 Vaccination: From Interesting Agent to the Patient |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">The vaccination for the novel Coronavirus (COVID-19) is undergoing its final stages of analysis and testing. It is an impressive feat under the circumstances that we are on the verge of a potential breakthrough vaccination. This will help reduce the stress for millions of people around the globe, helping to restore worldwide normalcy. In this review, the analysis looks into how the new branch of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) came into the forefront of the world like a pandemic. This review will break down the details of what COVID-19 is, the viral family it belongs to and its background of how this family of viruses alters bodily functions by attacking vital human respiratory organs, the circulatory system, the central nervous system and the gastrointestinal tract. This review also looks at the process a new drug analogue undergoes, from (i) being a promising lead compound to (ii) being released into the market, from the drug development and discovery stage right through to FDA approval and aftermarket research. This review also addresses viable reasoning as to why the SARS-CoV-2 vaccine may have taken much less time than normal in order for it to be released for use.</p><h2>Other Information</h2><p dir="ltr">Published in: Vaccines<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.3390/vaccines9020120" target="_blank">http://dx.doi.org/10.3390/vaccines9020120</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_2dbdd1063a7c38f1dd23322c7dd06841 |
| identifier_str_mv | 10.3390/vaccines9020120 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/23576073 |
| publishDate | 2021 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | COVID-19 Vaccination: From Interesting Agent to the PatientAnis Daou (16442181)Biomedical and clinical sciencesClinical sciencesImmunologyPharmacology and pharmaceutical sciencesCOVID-19vaccinationsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)drug development and discoverypandemic<p dir="ltr">The vaccination for the novel Coronavirus (COVID-19) is undergoing its final stages of analysis and testing. It is an impressive feat under the circumstances that we are on the verge of a potential breakthrough vaccination. This will help reduce the stress for millions of people around the globe, helping to restore worldwide normalcy. In this review, the analysis looks into how the new branch of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) came into the forefront of the world like a pandemic. This review will break down the details of what COVID-19 is, the viral family it belongs to and its background of how this family of viruses alters bodily functions by attacking vital human respiratory organs, the circulatory system, the central nervous system and the gastrointestinal tract. This review also looks at the process a new drug analogue undergoes, from (i) being a promising lead compound to (ii) being released into the market, from the drug development and discovery stage right through to FDA approval and aftermarket research. This review also addresses viable reasoning as to why the SARS-CoV-2 vaccine may have taken much less time than normal in order for it to be released for use.</p><h2>Other Information</h2><p dir="ltr">Published in: Vaccines<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.3390/vaccines9020120" target="_blank">http://dx.doi.org/10.3390/vaccines9020120</a></p>2021-01-03T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/vaccines9020120https://figshare.com/articles/journal_contribution/COVID-19_Vaccination_From_Interesting_Agent_to_the_Patient/23576073CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/235760732021-01-03T00:00:00Z |
| spellingShingle | COVID-19 Vaccination: From Interesting Agent to the Patient Anis Daou (16442181) Biomedical and clinical sciences Clinical sciences Immunology Pharmacology and pharmaceutical sciences COVID-19 vaccination severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drug development and discovery pandemic |
| status_str | publishedVersion |
| title | COVID-19 Vaccination: From Interesting Agent to the Patient |
| title_full | COVID-19 Vaccination: From Interesting Agent to the Patient |
| title_fullStr | COVID-19 Vaccination: From Interesting Agent to the Patient |
| title_full_unstemmed | COVID-19 Vaccination: From Interesting Agent to the Patient |
| title_short | COVID-19 Vaccination: From Interesting Agent to the Patient |
| title_sort | COVID-19 Vaccination: From Interesting Agent to the Patient |
| topic | Biomedical and clinical sciences Clinical sciences Immunology Pharmacology and pharmaceutical sciences COVID-19 vaccination severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drug development and discovery pandemic |